PPTS Portal Home

Revised 2025 (Resolution 4)

Document Navigator

Document Navigator

ACR–NASCI–SPR PRACTICE PARAMETER FOR THE PERFORMANCE OF BODY MAGNETIC RESONANCE ANGIOGRAPHY (MRA)

PREAMBLE

I.

INTRODUCTION

II.

INDICATIONS

A.

General Considerations

II.

INDICATIONS

B.

Specific Considerations

1.

Thoracic vasculature

II.

INDICATIONS

B.

Specific Considerations

2.

Extremity Evaluations

II.

INDICATIONS

B.

Specific Considerations

3.

Abdominal and pelvic vasculature

II.

INDICATIONS

B.

Specific Considerations

4.

Pediatric indications for body MRA

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

IV.

SPECIFICATIONS OF THE EXAMINATION

IV.

SPECIFICATIONS OF THE EXAMINATION

A.

Patient Selection and Preparation

IV.

SPECIFICATIONS OF THE EXAMINATION

B.

Facility Requirements

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

1.

Noncontrast MRA

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

2.

CE-MRA

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

3.

Special Considerations

V.

DOCUMENTATION

VI.

EQUIPMENT SPECIFICATIONS

VII.

QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION

ACKNOWLEDGEMENTS

Writing Committee – members represent their societies in the initial and final revision of this practice parameter

ACR
Casaburi, Larissa B. MD, MPH, Chair
Battey, Thomas W K MD
Collard, Michael MD
Hagspiel, Klaus MD
Lee, Yoo Jin MD
Rivard, Andrew L. MD

NASCI
Allen, Bradley D MD
Bergmann, Liisa MD
Karur, Gauri Rani MD
Young, Phillip M MD

SPR
Griffin, Lindsay M MD
Otero, Hansel J MD
Priya, Sarv MD
Smalley, Robert MD

Committee on Cardiovascular Imaging – Body Imaging

(ACR Committee responsible for sponsoring the draft through the process)

Hagspiel, Klaus MD, Chair	Blasco, Lucia Flors MD, PhD	Casaburi, Larissa B. MD, MPH	Lee, Yoo Jin MD
Prosper, Ashley MD	Rivard, Andrew L. MD

Committee on Practice Parameters and Technical Standards

(ACR Committee responsible for sponsoring the draft through the process)

Caplin, Drew M MD, Chair

Committee on Practice Parameters – Pediatric Imaging

(ACR Committee responsible for sponsoring the draft through the process)

Amodio, John B MD, Chair	Alizai, Hamza MD	Betz, Bradford W MD	Blumfield, Einat MD
Collard, Michael MD	Goldman-Yassen, Adam MD	Lai, Hollie A MD	Lala, Shailee V MD
Lasiecka, Zofia M MD, PhD	Laufer, Adina MD	Levin, Terry L MD	Li, Arleen MD
Maloney, John A MD	Noda, Sakura MD	Shah, Summit MD	Trout, Andrew T MD
Vatsky, Seth DO

Bulas, Dorothy I MD, Chair, Commission on Pediatric Radiology

Larson, David B MBA, MD, Chair, Commission on Quality and Safety

Rosenkrantz, Andrew MD, Chair, Commission on Body Imaging

Comments Reconciliation Committee

Optican, Robert MD - CSC, Co-Chair	Allen, Bradley D MD	Amodio, John B MD	Battey, Thomas W K MD
Bergmann, Liisa MD	Bulas, Dorothy I MD	Casaburi, Larissa B. MD, MPH	Collard, Michael MD
Griffin, Lindsay M MD	Hagspiel, Klaus MD	Karur, Gauri Rani MD	Larson, David B MBA, MD
Lee, Yoo Jin MD	Otero, Hansel J MD	Priya, Sarv MD	Rivard, Andrew L. MD
Rosenkrantz, Andrew MD	Smalley, Robert MD	Young, Phillip M MD

REFERENCES

1. Cantinotti M, Hegde S, Bell A, Razavi R. Diagnostic role of magnetic resonance imaging in identifying aortic arch anomalies. Congenit Heart Dis. 2008;3(2):117-23.
2. Ersoy H, Rybicki FJ. MR angiography of the lower extremities. AJR. 2008;190(6):1675-1684.
3. Koss SA, Yucel EK. Role of MR angiography in vascular interventional planning. Magn Reson Imaging Clin N Am. 2005 Feb;13(1):153-60, vi.
4. Lohan DG, Tomasian A, Krishnam M, Jonnala P, Blackwell KE, Finn JP. MR angiography of lower extremities at 3 T: presurgical planning of fibular free flap transfer for facial reconstruction. AJR Am J Roentgenol. 190(3):770-6, 2008 Mar.
5. Poschenrieder F, Hamer OW, Herold T, et al. Diagnostic accuracy of intraarterial and i.v. MR angiography for the detection of stenoses of the infrainguinal arteries. AJR Am J Roentgenol. 2009 Jan;192(1):117-21.
6. American College of Radiology. ACR–ASNR–SNIS–SPR Practice Parameter for the Performance of Cervicocerebral Magnetic Resonance Angiography (MRA). Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=73+&releaseId=2
7. American College of Radiology. ACR-NASCI-SPR Practice Parameter for the Performance and Interpretation of Cardiac Magnetic Resonance Imaging (MRI). Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=179+&releaseId=2
8. Grobner T. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006; 21(4):1104-1108.
9. Juluru K, Vogel-Claussen J, Macura KJ, Kamel IR, Steever A, Bluemke DA. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety. Radiographics. 2009;29(1):9-22.
10. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007 Mar;242(3):647-9.
11. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006 Sep;17(9):2359-62.
12. American College of Radiology. ACR Committee on Drugs and Contrast Media. Manual on Contrast Media. Available at: https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Contrast-Manual.
13. Hope MD, Hope TA, Zhu C, et al. Vascular Imaging With Ferumoxytol as a Contrast Agent. AJR 2015;205:W366-73.
14. Fananapazir G, Bashir MR, Corwin MT, Lamba R, Vu CT, Troppmann C. Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis. J Magn Reson Imaging. 45(3):779-785, 2017 03.
15. Lai LM, Cheng JY, Alley MT, Zhang T, Lustig M, Vasanawala SS. Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia. J Magn Reson Imaging. 45(5):1407-1418, 2017 05.
16. Lehrman ED, Plotnik AN, Hope T, Saloner D. Ferumoxytol-enhanced MRI in the peripheral vasculature. Clin Radiol. 2019 Jan;74(1):S0009-9260(18)30126-0.
17. Knobloch G, Colgan T, Schiebler ML, et al. Comparison of gadolinium-enhanced and ferumoxytol-enhanced conventional and UTE-MRA for the depiction of the pulmonary vasculature. Magn Reson Med. 2019 Nov;82(5):1660-1670.
18. Schubert T, Motosugi U, Kinner S, et al. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle. J Magn Reson Imaging. 2017 Jun;45(6):1617-1626.
19. Miyazaki M, Lee VS. Nonenhanced MR angiography. Radiology. 2008; 248(1):20-43.
20. Miyazaki M, Akahane M. Non-contrast enhanced MR angiography: Established techniques. J Magn Reson Imaging. 2012;35(1):1-19.
21. Morita S, Masukawa A, Suzuki K, Hirata M, Kojima S, Ueno E. Unenhanced MR angiography: techniques and clinical applications in patients with chronic kidney disease. Radiographics. 2011;31(2):E13-33.
22. Wheaton AJ, Miyazaki M. Non-contrast enhanced MR angiography: physical principles. J Magn Reson Imaging. 2012 Aug;36(2):286-304.
23. Gupta A, Baradaran H, Schweitzer AD, et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke 2013;44:3071-7.
24. Schindler A, Schinner R, Altaf N, et al. Prediction of Stroke Risk by Detection of Hemorrhage in Carotid Plaques: Meta-Analysis of Individual Patient Data. JACC Cardiovasc Imaging. 13(2 Pt 1):395-406, 2020 02.
25. Hellings WE, Peeters W, Moll FL, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation. 2010 May 04;121(17):1941-50.
26. American College of Radiology. ACR Practice Parameter for Performing and Interpreting Magnetic Resonance Imaging (MRI). Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=146+&releaseId=2
27. American College of Radiology. ACR–SIR Practice Parameter For Minimal and/or Moderate Sedation/Analgesia. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=95+&releaseId=2
28. Geard CR, Osmak RS, Hall EJ, Simon HE, Maudsley AA, Hilal SK. Magnetic resonance and ionizing radiation: a comparative evaluation in vitro of oncogenic and genotoxic potential. Radiology. 1984 Jul;152(1):199-202.
29. Chung T. Magnetic resonance angiography of the body in pediatric patients: experience with a contrast-enhanced time-resolved technique. Pediatr Radiol. 2005 Jan;35(1):3-10.
30. Grist TM, Thornton FJ. Magnetic resonance angiography in children: technique, indications, and imaging findings. Pediatr Radiol. 2005 Jan;35(1):26-39.
31. Uçar T, Fitoz S, Tutar E, Atalay S, Uysalel A. Diagnostic tools in the preoperative evaluation of children with anomalous pulmonary venous connections. Int J Cardiovasc Imaging. 2008 Feb;24(2):229-35.
32. American College of Radiology. ACR–SPR Practice Parameter for the use of Intravascular Contrast Media. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=142+&releaseId=2
33. American College of Radiology. ACR Committee on MR Safety. 2024 ACR Manual on MR Safety. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Radiology-Safety/Manual-on-MR-Safety.pdf.
34. McGuirt D. Alternatives to Sedation and General Anesthesia in Pediatric Magnetic Resonance Imaging: A Literature Review. Radiol Technol. 2016 Sep;88(1):18-26.
35. Edwards AD, Arthurs OJ. Paediatric MRI under sedation: is it necessary? What is the evidence for the alternatives?. Pediatr Radiol. 2011 Nov;41(11):1353-64.
36. Lemaire C, Moran GR, Swan H. Impact of audio/visual systems on pediatric sedation in magnetic resonance imaging. J Magn Reson Imaging. 2009 Sep;30(3):649-55.
37. Windram J, Grosse-Wortmann L, Shariat M, Greer ML, Crawford MW, Yoo SJ. Cardiovascular MRI without sedation or general anesthesia using a feed-and-sleep technique in neonates and infants. Pediatr Radiol. 2012 Feb;42(2):183-7.
38. American College of Cardiology Foundation Task Force on Expert Consensus Documents, Hundley WG, Bluemke DA, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. [Review] [426 refs]. J Am Coll Cardiol. 55(23):2614-62, 2010 Jun 08.
39. Lohan DG, Saleh R, Nael K, Krishnam M, Finn JP. Contrast-enhacend MRA versus nonenhanced MRA: pros and cons. Appl Radiol 2007;36 (suppl):3-15.
40. Kramer H, Nikolaou K, Sommer W, Reiser MF, Herrmann KA. Peripheral MR angiography. Magn Reson Imaging Clin N Am. 2009 Feb;17(1):91-100.
41. Morelli JN, Gerdes CM, Schmitt P, et al. Technical considerations in MR angiography: an image-based guide. J Magn Reson Imaging. 2013 Jun;37(6):1326-41.
42. Michaely HJ, Attenberger UI, Kramer H, Nael K, Reiser MF, Schoenberg SO. Abdominal and pelvic MR angiography. Magn Reson Imaging Clin N Am. 2007 Aug;15(3):301-14, v-vi.
43. Prince MR. Gadolinium-enhanced MR aortography. Radiology. 1994 Apr;191(1):155-64.
44. Prince MR. Body MR angiography with gadolinium contrast agents. Magn Reson Imaging Clin N Am. 1996 Feb;4(1):11-24.
45. Hartung MP, Grist TM, Francois CJ. Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson 2011;13:19.
46. Umutlu L, Maderwald S, Kinner S, et al. First-pass contrast-enhanced renal MRA at 7 Tesla: initial results. Eur Radiol. 2013 Apr;23(4):1059-66.
47. van den Bosch HC, Westenberg JJ, Caris R, et al. Peripheral arterial occlusive disease: 3.0-T versus 1.5-T MR angiography compared with digital subtraction angiography. Radiology. 2013 Jan;266(1):337-46.
48. Coenegrachts KL, Hoogeveen RM, Vaninbroukx JA, et al. High-spatial-resolution 3D balanced turbo field-echo technique for MR angiography of the renal arteries: initial experience. Radiology. 2004 Apr;231(1):237-42.
49. Katoh M, Buecker A, Stuber M, Günther RW, Spuentrup E. Free-breathing renal MR angiography with steady-state free-precession (SSFP) and slab-selective spin inversion: initial results. Kidney Int. 2004 Sep;66(3):1272-8.
50. Cukur T, Lee JH, Bangerter NK, Hargreaves BA, Nishimura DG. Non-contrast-enhanced flow-independent peripheral MR angiography with balanced SSFP. Magn Reson Med. 2009 Jun;61(6):1533-9.
51. Steffens JC, Link J, Schwarzenberg H, Mueller-Huelsbeck S, Brinkmann G, Heller M. Lower extremity occlusive disease: diagnostic imaging with a combination of cardiac-gated 2D phase-contrast and cardiac-gated 2D time-of-flight MRA. J Comput Assist Tomogr. 1999;23(1):7-12.
52. Glickerman DJ, Obregon RG, Schmiedl UP, et al. Cardiac-gated MR angiography of the entire lower extremity: a prospective comparison with conventional angiography. AJR Am J Roentgenol. 1996 Aug;167(2):445-51.
53. Hansmann J, Morelli JN, Michaely HJ, et al. Nonenhanced ECG-gated quiescent-interval single shot MRA: image quality and stenosis assessment at 3 tesla compared with contrast-enhanced MRA and digital subtraction angiography. J Magn Reson Imaging. 2014;39(6):1486-1493.
54. Wagner M, Knobloch G, Gielen M, et al. Nonenhanced peripheral MR-angiography (MRA) at 3 Tesla: evaluation of quiescent-interval single-shot MRA in patients undergoing digital subtraction angiography. Int J Cardiovasc Imaging. 31(4):841-50, 2015 Apr.
55. Varga-Szemes A, Wichmann JL, Schoepf UJ, et al. Accuracy of Noncontrast Quiescent-Interval Single-Shot Lower Extremity MR Angiography Versus CT Angiography for Diagnosis of Peripheral Artery Disease: Comparison With Digital Subtraction Angiography. JACC Cardiovasc Imaging. 10(10 Pt A):1116-1124, 2017 10.
56. Edelman RR, Carr M, Koktzoglou I. Advances in non-contrast quiescent-interval slice-selective (QISS) magnetic resonance angiography. Clin Radiol. 2019 Jan;74(1):S0009-9260(17)30567-6.
57. Sebastia C, Sotomayor AD, Pano B, et al. Accuracy of unenhanced magnetic resonance angiography for the assessment of renal artery stenosis. Eur J Radiol Open. 3:200-6, 2016.
58. Edelman RR, Koktzoglou I. Noncontrast MR angiography: An update. J Magn Reson Imaging 2019;49:355-73.
59. Hoey ET, Ganeshan A, Puni R, Henderson J, Crowe PM. Fresh blood imaging of the peripheral vasculature: an emerging unenhanced MR technique. AJR Am J Roentgenol. 2010; 195(6):1444-1448.
60. Miyazaki M, Isoda H. Non-contrast-enhanced MR angiography of the abdomen. Eur J Radiol. 2011 Oct;80(1):9-23.
61. Fan Z, Sheehan J, Bi X, Liu X, Carr J, Li D. 3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP. Magn Reson Med. 2009 Dec;62(6):1523-32.
62. Sheehan JJ, Fan Z, Davarpanah AH, et al. Nonenhanced MR angiography of the hand with flow-sensitive dephasing-prepared balanced SSFP sequence: initial experience with systemic sclerosis. Radiology. 2011 Apr;259(1):248-56.
63. Priest AN, Joubert I, Winterbottom AP, See TC, Graves MJ, Lomas DJ. Initial clinical evaluation of a non-contrast-enhanced MR angiography method in the distal lower extremities. Magn Reson Med. 2013 Dec;70(6):1644-52.
64. Nael K, Moriarty JM, Finn JP. Low dose CE-MRA. Eur J Radiol. 2011;80(1):2-8.
65. Bashir MR, Jaffe TA, Brennan TV, Patel UD, Ellis MJ. Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. Transplantation. 96(1):91-6, 2013 Jul 15.
66. Sabach AS, Bruno M, Kim D, et al. Gadofosveset trisodium: abdominal and peripheral vascular applications. AJR Am J Roentgenol. 2013 Jun;200(6):1378-86.
67. Kanda T, Nakai Y, Oba H, Toyoda K, Kitajima K, Furui S. Gadolinium deposition in the brain. Magn Reson Imaging. 2016 Dec;34(10):S0730-725X(16)30139-4.
68. Layne KA, Dargan PI, Archer JRH, Wood DM. Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents. Br J Clin Pharmacol. 2018 Nov;84(11):2522-2534.
69. Hahn WY, Hecht EM, Friedman B, Babb JS, Jacobowitz GR, Lee VS. Distal lower extremity imaging: prospective comparison of 2-dimensional time of flight, 3-dimensional time-resolved contrast-enhanced magnetic resonance angiography, and 3-dimensional bolus chase contrast-enhanced magnetic resonance angiography. J Comput Assist Tomogr. 2007; 31(1):29-36.
70. Vogt FM, Goyen M, Debatin JF. MR angiography of the chest. Radiol Clin North Am. 2003 Jan;41(1):29-41.
71. Herborn CU, Goyen M, Lauenstein TC, Debatin JF, Ruehm SG, Kröger K. Comprehensive time-resolved MRI of peripheral vascular malformations. AJR Am J Roentgenol. 2003 Sep;181(3):729-35.
72. Du J, Thornton FJ, Mistretta CA, Grist TM. Dynamic MR venography: an intrinsic benefit of time-resolved MR angiography. J Magn Reson Imaging. 2006 Oct;24(4):922-7.
73. Mohrs OK, Petersen SE, Voigtlaender T, et al. Time-resolved contrast-enhanced MR angiography of the thorax in adults with congenital heart disease. AJR Am J Roentgenol. 2006;187(4):1107-1114.
74. Cantwell CP, Cradock A, Bruzzi J, Fitzpatrick P, Eustace S, Murray JG. MR venography with true fast imaging with steady-state precession for suspected lower-limb deep vein thrombosis. J Vasc Interv Radiol. 2006;17(11 Pt 1):1763-1769.
75. Koizumi J, Horie T, Muro I, et al. Magnetic resonance venography of the lower limb. Int Angiol. 2007 Jun;26(2):171-82.
76. Kim CY, Mirza RA, Bryant JA, et al. Central veins of the chest: evaluation with time-resolved MR angiography. Radiology. 2008;247(2):558-566.
77. Dick EA, Burnett C, Anstee A, Hamady M, Black D, Gedroyc WM. Time-resolved imaging of contrast kinetics three-dimensional (3D) magnetic resonance venography in patients with pelvic congestion syndrome. Br J Radiol. 2010;83(994):882-887.
78. Kirby JM, Burrows D, Haider E, Maizlin Z, Midia M. Utility of MRI before and after uterine fibroid embolization: why to do it and what to look for. [Review]. Cardiovasc Intervent Radiol. 34(4):705-16, 2011 Aug.
79. Zou Z, Kate Lee H, Levine JL, et al. Gadofosveset trisodium-enhanced abdominal perforator MRA. J Magn Reson Imaging. 2012 Mar;35(3):711-6.
80. Nielsen YW, Thomsen HS. Contrast-enhanced peripheral MRA: technique and contrast agents. Acta Radiol. 2012 Sep 01;53(7):769-77.
81. Kramer JH, Grist TM. Peripheral MR Angiography. Magn Reson Imaging Clin N Am. 2012 Nov;20(4):S1064-9689(12)00094-3.
82. Fink C, Henzler T, Shirinova A, Apfaltrer P, Wasser K. Thoracic magnetic resonance imaging: pulmonary thromboembolism. [Review]. Journal of Thoracic Imaging. 28(3):171-7, 2013 May.
83. Vasanawala SS, Chan FP, Newman B, Alley MT. Combined respiratory and cardiac triggering improves blood pool contrast-enhanced pediatric cardiovascular MRI. Pediatr Radiol. 2011 Dec;41(12):1536-44.
84. Young PM, McGee KP, Pieper MS, et al. Tips and tricks for MR angiography of pediatric and adult congenital cardiovascular diseases. AJR Am J Roentgenol. 2013 May;200(5):980-8.
85. Meaney JF, Ridgway JP, Chakraverty S, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology. 1999 Apr;211(1):59-67.
86. Kita M, Mitani Y, Tanihata H, et al. Moving-table reduced-dose gadolinium-enhanced three-dimensional magnetic resonance angiography: velocity-dependent method with three-phase gadolinium infusion. J Magn Reson Imaging. 2001 Sep;14(3):319-28.
87. Ho KY, Leiner T, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM. Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology. 1998 Mar;206(3):683-92.
88. Sodickson DK, McKenzie CA, Li W, Wolff S, Manning WJ, Edelman RR. Contrast-enhanced 3D MR angiography with simultaneous acquisition of spatial harmonics: A pilot study. Radiology. 2000 Oct;217(1):284-9.
89. Andreisek G, Pfammatter T, Goepfert K, et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology. 2007;242(2):610-620.
90. Sutter R, Nanz D, Lutz AM, et al. Assessment of aortoiliac and renal arteries: MR angiography with parallel acquisition versus conventional MR angiography and digital subtraction angiography. Radiology. 245(1):276-84, 2007 Oct.
91. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med. 1996 Sep;36(3):345-51.
92. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology. 1996 Dec;201(3):705-10.
93. Prince MR, Schoenberg SO, Ward JS, Londy FJ, Wakefield TW, Stanley JC. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology. 1997; 205(1):128-136.
94. Wilman AH, Riederer SJ, King BF, Debbins JP, Rossman PJ, Ehman RL. Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: application to the renal arteries. Radiology. 1997 Oct;205(1):137-46.
95. Foo TK, Ho VB, Marcos HB, Hood MN, Choyke PL. MR angiography using steady-state free precession. Magn Reson Med. 2002 Oct;48(4):699-706.
96. Bashir MR, Bhatti L, Marin D, Nelson RC. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging. 2015 Apr;41(4):884-98.
97. Adams LC, Jayapal P, Ramasamy SK, et al. Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art. AJR Am J Roentgenol. 2023 Apr;220(4):590-603.
98. Thornton MJ, Ryan R, Varghese JC, Farrell MA, Lucey B, Lee MJ. A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins. AJR Am J Roentgenol. 1999 Oct;173(4):999-1003.
99. Bremerich J, Bilecen D, Reimer P. MR angiography with blood pool contrast agents. Eur Radiol. 2007 Dec;17(12):3017-24.
100. Dillman JR, Trout AT, Merrow AC, et al. Non-contrast three-dimensional gradient recalled echo Dixon-based magnetic resonance angiography/venography in children. Pediatr Radiol. 2019 Mar;49(3):407-414.
101. Ito K, Koike S, Shimizu A, et al. Portal venous system: evaluation with unenhanced MR angiography with a single-breath-hold ECG-synchronized 3D half-Fourier fast spin-echo sequence. AJR Am J Roentgenol. 2008 Aug;191(2):550-4.
102. Pandey T, Shaikh R, Viswamitra S, Jambhekar K. Use of time resolved magnetic resonance imaging in the diagnosis of pelvic congestion syndrome. J Magn Reson Imaging. 2010 Sep;32(3):700-4.
103. Mallouhi A, Schocke M, Judmaier W, et al. 3D MR angiography of renal arteries: comparison of volume rendering and maximum intensity projection algorithms. Radiology. 2002 May;223(2):509-16.
104. Fink C, Hallscheidt PJ, Hosch WP, et al. Preoperative evaluation of living renal donors: value of contrast-enhanced 3D magnetic resonance angiography and comparison of three rendering algorithms. Eur Radiol. 2003 Apr;13(4):794-801.
105. Persson A, Dahlstrom N, Engellau L, Larsson EM, Brismar TB, Smedby O. Volume rendering compared with maximum intensity projection for magnetic resonance angiography measurements of the abdominal aorta. Acta Radiol. 45(4):453-9, 2004 Jul.
106. Wehrschuetz M, Aschauer M, Portugaller H, et al. Review of source images is necessary for the evaluation of gadolinium-enhanced MR angiography for renal artery stenosis. Cardiovasc Intervent Radiol. 2004;27(5):441-6.
107. Glockner JF. MR angiography interpretation: techniques and pitfalls. Magn Reson Imaging Clin N Am. 2005 Feb;13(1):23-40, v.
108. Runck F, Steiner RP, Bautz WA, Lell MM. MR imaging: influence of imaging technique and postprocessing on measurement of internal carotid artery stenosis. AJNR Am J Neuroradiol. 2008 Oct;29(9):1736-42.
109. Kaufman JA, McCarter D, Geller SC, Waltman AC. Two-dimensional time-of-flight MR angiography of the lower extremities: artifacts and pitfalls. AJR Am J Roentgenol. 1998 Jul;171(1):129-35.
110. American College of Radiology. ACR practice guideline for communication: diagnostic radiology. In: Practice guidelines and technical standards, 2004. Reston, VA: American College of Radiology 2004; 5–7
111. American College of Radiology. ACR–AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of Magnetic Resonance (MR) Imaging Equipment. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=57+&releaseId=2